# EPHB1

## Overview
EPHB1 is a gene that encodes the EPH receptor B1, a member of the Eph receptor family, which is the largest group of receptor tyrosine kinases. The EPH receptor B1 is a transmembrane protein that plays a pivotal role in cell signaling, particularly in the nervous system, where it is involved in processes such as synapse formation, neural progenitor regulation, and cell positioning. The receptor functions through bidirectional signaling with ephrin ligands, influencing cellular organization and communication. EPHB1 is expressed in various regions of the brain, including the olfactory bulb, hippocampus, and cerebellum, and is crucial for maintaining neural architecture and function. Alterations in the EPHB1 gene have been linked to several diseases, including amyotrophic lateral sclerosis (ALS) and various cancers, where mutations can disrupt normal signaling pathways and contribute to disease progression (Wei2017Paradoxes; Kundu2023Recurring).

## Structure
EPHB1, a member of the Eph receptor family, is a receptor tyrosine kinase with a complex molecular structure. The primary structure of EPHB1 consists of a sequence of amino acids that form the protein. Its secondary structure includes alpha helices and beta sheets, which contribute to the protein's stability and function (Liang2019Eph).

The tertiary structure of EPHB1 is characterized by a three-dimensional folding that includes several key domains: a ligand-binding domain (LBD), a transmembrane segment, and a cytoplasmic kinase domain. The LBD is crucial for interactions with ephrin ligands, while the kinase domain is involved in signal transduction (Liang2019Eph; Kundu2023Recurring). The kinase domain also contains a conserved caveolin-1 scaffold binding domain (CSDBM), which is important for interactions with caveolin-1 in endothelial cells (Tiruppathi2020EphB1).

Post-translational modifications, such as phosphorylation, play a significant role in EPHB1's function. Phosphorylation of specific tyrosine residues is essential for receptor activation and downstream signaling (Kundu2023Recurring; Tiruppathi2020EphB1). EPHB1 may also undergo SUMOylation, with lysine 785 identified as a major site for this modification, affecting its activity (Chen2018Sumoylation).

EPHB1 can form dimers or oligomers, which are important for its signaling functions. These interactions are facilitated by specific structural interfaces within the receptor (Liang2019Eph). Splice variant isoforms of EPHB1 may exist, potentially altering its functional properties (Liang2019Eph).

## Function
EPHB1, a member of the Eph receptor family, is a receptor tyrosine kinase involved in various cellular processes through bidirectional signaling with ephrin ligands. In healthy human cells, EPHB1 is expressed in regions such as the olfactory bulb, hippocampus, and cerebellum, playing a crucial role in synapse formation and maturation, dendritic spine morphogenesis, and synapse development in the hippocampus (Wei2017Paradoxes). EPHB1 is essential for the regulation of neural progenitors, influencing their proliferation, migration, and organization in the hippocampus. It is involved in the proper positioning of neural progenitors and the rerouting of retinal ganglion cell projections, highlighting its importance in neurogenesis and neural communication (Wei2017Paradoxes).

EPHB1 also interacts with ephrin-B3 to regulate the positioning of neural stem/progenitor cells in the subgranular zone (SGZ) of the hippocampus, preventing abnormal cellular processes from invading the hilus (Chumley2007EphB). This interaction is crucial for maintaining proper neural cell organization and function. EPHB1 signaling is involved in inhibiting stem cell proliferation in the adult brain, maintaining a balance between stem cell quiescence and proliferation (Kania2016Mechanisms).

## Clinical Significance
Mutations and alterations in the EPHB1 gene have been implicated in various diseases, particularly amyotrophic lateral sclerosis (ALS) and certain cancers. In ALS, the EphB1 gene is involved in neuron-to-astrocyte communication, which is crucial for neuroprotection. However, in ALS models, this signaling pathway is disrupted, leading to a failure in activating the protective astrocyte state through STAT3 signaling. This dysfunction is observed in both mouse models and human ALS patient-derived astrocytes, where there is an upregulation of proinflammatory transcripts and a downregulation of protective transcripts associated with EphB1 signaling (Tyzack2017A).

In the context of cancer, EPHB1 mutations are frequently observed in colorectal cancer and other types such as uterine corpus endometrial carcinoma and lung adenocarcinoma. These mutations often occur in the ligand-binding and kinase domains, affecting receptor signaling and cellular compartmentalization. Such alterations can lead to changes in pathways like PI3K-Akt, MAPK, and JAK-STAT, contributing to tumor growth, invasiveness, and metastasis. The mutations result in reduced receptor phosphorylation and altered cellular behavior, which may play a role in cancer progression (Kundu2023Recurring).

## Interactions
EPHB1 interacts with several proteins, playing a crucial role in various cellular signaling pathways. One significant interaction is with the adapter protein Nck, which binds to the phosphorylated tyrosine residue 594 (Tyr 594) on EPHB1. This interaction is essential for the activation of the c-Jun N-terminal kinase (JNK) signaling pathway, which is involved in cytoskeletal rearrangements necessary for cell-cell aggregation and targeting functions (Stein1998Nck). The interaction between EPHB1 and Nck also facilitates the recruitment of Caskin1, forming a multiprotein complex that plays a role in neuronal cells (Pesti2012Complex).

EPHB1 also interacts with caveolin-1 (Cav-1) in endothelial cells. This interaction is crucial for caveolae biogenesis and function. Upon activation by ephrin B1, EPHB1 undergoes phosphorylation, leading to the phosphorylation of Cav-1 by Src kinase, which is necessary for caveolae-mediated endocytosis and trafficking (Tiruppathi2020EphB1).

Additionally, EPHB1 recruits other adapter proteins such as Grb2 and Grb10 through different subdomains. Grb10 binds through Tyr 929, while Grb2 interacts with residues within the catalytic domain, highlighting the complex network of protein interactions involving EPHB1 (Stein1998Nck).


## References


[1. (Chumley2007EphB) Michael J. Chumley, Timothy Catchpole, Robert E. Silvany, Steven G. Kernie, and Mark Henkemeyer. Ephb receptors regulate stem/progenitor cell proliferation, migration, and polarity during hippocampal neurogenesis. The Journal of Neuroscience, 27(49):13481–13490, December 2007. URL: http://dx.doi.org/10.1523/JNEUROSCI.4158-07.2007, doi:10.1523/jneurosci.4158-07.2007. This article has 165 citations.](https://doi.org/10.1523/JNEUROSCI.4158-07.2007)

[2. (Kania2016Mechanisms) Artur Kania and Rüdiger Klein. Mechanisms of ephrin–eph signalling in development, physiology and disease. Nature Reviews Molecular Cell Biology, 17(4):240–256, January 2016. URL: http://dx.doi.org/10.1038/nrm.2015.16, doi:10.1038/nrm.2015.16. This article has 517 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm.2015.16)

[3. (Tyzack2017A) Giulia E. Tyzack, Claire E. Hall, Christopher R. Sibley, Tomasz Cymes, Serhiy Forostyak, Giulia Carlino, Ione F. Meyer, Giampietro Schiavo, Su-Chun Zhang, George M. Gibbons, Jia Newcombe, Rickie Patani, and András Lakatos. A neuroprotective astrocyte state is induced by neuronal signal ephb1 but fails in als models. Nature Communications, October 2017. URL: http://dx.doi.org/10.1038/s41467-017-01283-z, doi:10.1038/s41467-017-01283-z. This article has 106 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-01283-z)

[4. (Pesti2012Complex) Szabolcs Pesti, Annamária Balázs, Roopesh Udupa, Beáta Szabó, Anna Fekete, Gábor Bőgel, and László Buday. Complex formation of ephb1/nck/caskin1 leads to tyrosine phosphorylation and structural changes of the caskin1 sh3 domain. Cell Communication and Signaling, November 2012. URL: http://dx.doi.org/10.1186/1478-811X-10-36, doi:10.1186/1478-811x-10-36. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1478-811X-10-36)

[5. (Kundu2023Recurring) Snehangshu Kundu, Luís Nunes, Jeremy Adler, Lucy Mathot, Ivaylo Stoimenov, and Tobias Sjöblom. Recurring ephb1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells. Cell Communication and Signaling, December 2023. URL: http://dx.doi.org/10.1186/s12964-023-01378-9, doi:10.1186/s12964-023-01378-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-023-01378-9)

[6. (Tiruppathi2020EphB1) Chinnaswamy Tiruppathi, Sushil C. Regmi, Dong-Mei Wang, Gary C. H. Mo, Peter T. Toth, Stephen M. Vogel, Radu V. Stan, Mark Henkemeyer, Richard D. Minshall, Jalees Rehman, and Asrar B. Malik. Ephb1 interaction with caveolin-1 in endothelial cells modulates caveolae biogenesis. Molecular Biology of the Cell, 31(11):1167–1182, May 2020. URL: http://dx.doi.org/10.1091/mbc.E19-12-0713, doi:10.1091/mbc.e19-12-0713. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E19-12-0713)

[7. (Stein1998Nck) Elke Stein, Uyen Huynh-Do, Andrew A. Lane, Douglas P. Cerretti, and Thomas O. Daniel. Nck recruitment to eph receptor, ephb1/elk, couples ligand activation to c-jun kinase. Journal of Biological Chemistry, 273(3):1303–1308, January 1998. URL: http://dx.doi.org/10.1074/jbc.273.3.1303, doi:10.1074/jbc.273.3.1303. This article has 131 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.3.1303)

[8. (Liang2019Eph) Lung-Yu Liang, Onisha Patel, Peter W. Janes, James M. Murphy, and Isabelle S. Lucet. Eph receptor signalling: from catalytic to non-catalytic functions. Oncogene, 38(39):6567–6584, August 2019. URL: http://dx.doi.org/10.1038/s41388-019-0931-2, doi:10.1038/s41388-019-0931-2. This article has 93 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-019-0931-2)

[9. (Wei2017Paradoxes) Wenqiang Wei, Hongju Wang, and Shaoping Ji. Paradoxes of the ephb1 receptor in malignant brain tumors. Cancer Cell International, February 2017. URL: http://dx.doi.org/10.1186/s12935-017-0384-z, doi:10.1186/s12935-017-0384-z. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-017-0384-z)

[10. (Chen2018Sumoylation) Qin Chen, Rong Deng, Xian Zhao, Haihua Yuan, Hailong Zhang, Jinzhuo Dou, Ran Chen, Hui Jin, Yanli Wang, Jian Huang, and Jianxiu Yu. Sumoylation of ephb1 suppresses neuroblastoma tumorigenesis via inhibiting pkcγ activation. Cellular Physiology and Biochemistry, 45(6):2283–2292, 2018. URL: http://dx.doi.org/10.1159/000488174, doi:10.1159/000488174. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1159/000488174)